Skip to main content
2025 CRT Conference Main banner
Back

James E. Muller, MD

Cardiologist, Brigham and Women's Hospital, Boston, MA 02115
Brigham and Women's Hospital
Auburndale , Massachusetts, United States

Dr. Muller is a research cardiologist at Harvard Medical School. He is also CEO of ECHAS, LLC, a company building an app guiding calls to 911 for a heart attack. In the 1980s studies of circadian variation and triggering led to the concept of vulnerable coronary plaque. In 1998 he founded Infraredx, Inc to create a NIRS-IVUS catheter. Dr. Ron Waksman led the first prospective study demonstrating that NIRS can identify vulnerable plaques. The PROSPECT 2 study and 8 other studies demonstrated detection of vulnerable plaques. He co-founded SpectraWAVE, Inc. which has created an OCT-NIRS coronary catheter approved by the FDA for detection of high risk plaques. In 2023 he was Scientist of the Year by the ACC. In 1980 he was a cofounder of International Physicians for Prevention of Nuclear War (IPPNW) winner of the 1985 Nobel Peace Prize.

Disclosure(s): Spectrawave: Consultant (Ongoing), Stock-privately held company (Ongoing)

Presentation(s):

Email James